Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.25
+0.13 (2.12%)
Nov 21, 2024, 12:13 PM EST - Market open
Lexeo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 207 | 358 | - | - | - |
| Enterprise Value | 56 | 523 | - | - | - |
| Last Close Price | 6.12 | 13.42 | - | - | - |
| PB Ratio | 1.45 | 3.15 | - | - | - |
| P/TBV Ratio | 2.15 | 3.15 | - | - | - |
| Debt / Equity Ratio | 0.07 | 0.10 | 0.19 | - | - |
| Asset Turnover | - | - | 0.01 | 0.02 | - |
| Quick Ratio | 5.86 | 7.05 | 5.39 | 18.24 | 42.10 |
| Current Ratio | 5.95 | 7.21 | 5.58 | 18.35 | 42.15 |
| Return on Equity (ROE) | -107.21% | -71.54% | -58.84% | -65.27% | - |
| Return on Assets (ROA) | -51.05% | -36.15% | -32.33% | -38.07% | - |
| Return on Capital (ROIC) | -62.02% | -40.64% | -35.18% | -40.81% | - |
| Earnings Yield | -42.79% | -18.57% | - | - | - |
| FCF Yield | -33.29% | -16.67% | - | - | - |
| Buyback Yield / Dilution | -1601.39% | -228.42% | -5.00% | -7.72% | - |
| Total Shareholder Return | -1601.39% | -228.42% | -5.00% | -7.72% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.